Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
Title | Eligo | In vivo gene editing of novel |
Description | [2022.10.03] Eligo Bioscience secures additional landmark CRISPR Eligo Bioscience is deploying in vivo gene editing technologies against microbiome targets to address diseases with high unmet |
Keywords | N/A |
WebSite | eligo-bioscience.com |
Host IP | 216.239.34.21 |
Location | United States |
Site | Rank |
US$955
Last updated: 2023-05-14 12:48:21
eligo-bioscience.com has Semrush global rank of 0. eligo-bioscience.com has an estimated worth of US$ 955, based on its estimated Ads revenue. eligo-bioscience.com receives approximately 110 unique visitors each day. Its web server is located in United States, with IP address 216.239.34.21. According to SiteAdvisor, eligo-bioscience.com is safe to visit. |
Purchase/Sale Value | US$955 |
Daily Ads Revenue | US$0 |
Monthly Ads Revenue | US$26 |
Yearly Ads Revenue | US$317 |
Daily Unique Visitors | 7 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
eligo-bioscience.com. | A | 3600 | IP: 216.239.34.21 |
eligo-bioscience.com. | A | 3600 | IP: 216.239.36.21 |
eligo-bioscience.com. | A | 3600 | IP: 216.239.38.21 |
eligo-bioscience.com. | A | 3600 | IP: 216.239.32.21 |
eligo-bioscience.com. | AAAA | 3600 | IPV6: 2001:4860:4802:38::15 |
eligo-bioscience.com. | AAAA | 3600 | IPV6: 2001:4860:4802:36::15 |
eligo-bioscience.com. | AAAA | 3600 | IPV6: 2001:4860:4802:32::15 |
eligo-bioscience.com. | AAAA | 3600 | IPV6: 2001:4860:4802:34::15 |
eligo-bioscience.com. | NS | 21600 | NS Record: ns-cloud-c3.googledomains.com. |
eligo-bioscience.com. | NS | 21600 | NS Record: ns-cloud-c2.googledomains.com. |
eligo-bioscience.com. | NS | 21600 | NS Record: ns-cloud-c4.googledomains.com. |
eligo-bioscience.com. | NS | 21600 | NS Record: ns-cloud-c1.googledomains.com. |
eligo-bioscience.com. | MX | 3600 | MX Record: 10 alt3.aspmx.l.google.com. |
eligo-bioscience.com. | MX | 3600 | MX Record: 1 aspmx.l.google.com. |
eligo-bioscience.com. | MX | 3600 | MX Record: 5 alt1.aspmx.l.google.com. |
eligo-bioscience.com. | MX | 3600 | MX Record: 5 alt2.aspmx.l.google.com. |
eligo-bioscience.com. | MX | 3600 | MX Record: 10 alt4.aspmx.l.google.com. |
eligo-bioscience.com. | TXT | 3600 | TXT Record: v=spf1 include:_spf.google.com ~all |
eligo-bioscience.com. | TXT | 3600 | TXT Record: apple-domain-verification=z8YETYgE3IaQgMtX |
Home Platform IP Partnering About us News & Press Careers of novel targets In vivo gene editing Featured news [2022.10.03] Eligo Bioscience secures additional landmark CRISPR patent Link to Press Release [2022.10.03] Eligo demonstrates for the first time that in situ base editing of the microbiome can be achieved with high efficiency Link to the BiorXiv preprint The human body harbors more than 250 million bacterial genes The interactions between the gene repertoire of the microbiome and the immune system of the host play a pivotal role in health and disease. The human body harbors more than 250 million bacterial genes The interactions between the gene repertoire of the microbiome and the immune system of the host play a pivotal role in health and disease. The presence or absence of a single bacterial gene can trigger or aggravate a variety of diseases I This genetic causality is being demonstrated in a growing number of therapeutic areas Introducing our GEM (Gene Editing of the |
HTTP/1.1 301 Moved Permanently Location: https://eligo.bio/ Date: Thu, 23 Dec 2021 10:45:29 GMT Content-Type: text/html; charset=UTF-8 Server: ghs Content-Length: 215 X-XSS-Protection: 0 X-Frame-Options: SAMEORIGIN HTTP/2 200 date: Thu, 23 Dec 2021 10:45:29 GMT content-type: text/html; charset=utf-8 vary: Accept-Encoding cdn-pullzone: 131628 cdn-uid: 25e272f5-167d-4855-b99f-3c8d13b1518a cdn-requestcountrycode: US cache-control: public, max-age=0, s-maxage=604800 last-modified: Thu, 09 Dec 2021 16:09:09 GMT x-amz-id-2: CnBKnQjt2Lp3zMRY0W2GLsxF3o/mHIe6mhqY1cVvxbvd+8RXhmBbXiYpe0TvKVi+wjVq85piQq4= x-amz-request-id: 4HBGJF2M7MC09Z3R x-amz-version-id: ulyiR5aTK5iQUySP8xAzPeKRB9GedY4T cdn-proxyver: 1.02 cdn-requestpullsuccess: True cdn-requestpullcode: 206 cdn-cachedat: 12/09/2021 16:59:00 cdn-edgestorageid: 742 cdn-status: 200 cdn-requestid: a0d19ffac7c62dd2b58348c87d6ddc0e cdn-cache: HIT cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" report-to: {"endpoints":[{"url":"https:\/\/a.nel.cloudflare.com\/report\/v3?s=8PU436egYCVzKDg10PpvhSujtPGrKoNjbSmCFcu7sgaGt682wA2H%2F2wqZijxwnwU71fVZO8K4Jct3y%2FD7gjydMIak2kwuSFf6oAI6kMaO9HbpheTbA%2B6Q%2FrK3zQ%3D"}],"group":"cf-nel","max_age":604800} nel: {"success_fraction":0,"report_to":"cf-nel","max_age":604800} server: cloudflare cf-ray: 6c21002a6ac88c0f-EWR alt-svc: h3=":443"; ma=86400, h3-29=":443"; ma=86400, h3-28=":443"; ma=86400, h3-27=":443"; ma=86400 |
Domain Name: ELIGO-BIOSCIENCE.COM Registry Domain ID: 1891226615_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.google.com Registrar URL: http://domains.google.com Updated Date: 2021-12-19T14:53:21Z Creation Date: 2014-12-19T11:38:18Z Registry Expiry Date: 2022-12-19T11:38:18Z Registrar: Google LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: registrar-abuse@google.com Registrar Abuse Contact Phone: +1.8772376466 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Name Server: NS-CLOUD-C1.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C2.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C3.GOOGLEDOMAINS.COM Name Server: NS-CLOUD-C4.GOOGLEDOMAINS.COM DNSSEC: signedDelegation DNSSEC DS Data: 3185 8 2 00492FBF1F5D1094706177D8D956B03CF748F3FEA2AE1B95FB33D07ED8A9DD30 >>> Last update of whois database: 2021-12-26T07:46:51Z <<< |